Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 13.7B | 13.6B | 13.9B | 11.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 11.6B | 11.3B | -21.7B | 9.7B |
Operating income | 1.8B | 1.8B | 1.7B | 1.9B |
Non operating interest income | ||||
Income | 70M | 57M | — | — |
Expense | 46M | 46M | 379M | 39M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 2.9B | 1.9B | 1.8B |
Tax provision | 430M | 641M | 421M | 402M |
Net income | 1.6B | 2.3B | 1.5B | 1.4B |
Basic EPS | 1.9 | 2.6 | — | 1.5 |
Diluted EPS | 1.9 | 2.6 | — | 1.5 |
Basic average shares | 877.8M | 879.4M | — | 880.2M |
Diluted average shares | 877.8M | 879.4M | — | 880.2M |
EBITDA | 2.4B | 2.3B | 2.7B | 2.2B |
Net income from continuing op. | 1.6B | 2.3B | 1.5B | 1.4B |
Minority interests | 0 | 1M | -19M | -11M |
Preferred stock dividends | 0 | 0 | 0 | 0 |